Table 2. Distribution of the observed rs231775 genotype and allele frequencies in HT patients.
|
rs231775 Genotype frequency (%) |
|||||
|
Genotype |
HT Patient n=50 |
Control n=50 |
P-value |
Odds Ratio |
95% Cl |
|
9 (18%) |
0.015* |
3.30 |
1.33 to 8.16 |
||
|
AG |
25 (50%) |
35 (70%) |
0.066 |
0.38 |
0.15 to 0.94 |
|
GG |
4 (8%) |
6 (12%) |
1.00 |
0.96 |
0.26 to 3.54 |
|
HWE-P |
0.3554 |
0.0042* |
|
|
|
|
Allele frequency (%) |
|||||
|
Allele |
HT Patient n=50 |
Control n=50 |
P-value |
Odds Ratio |
95% Cl |
|
A |
67 (67 %) |
53 (53 %) |
0.044* 0.044* |
1.8 |
1.02 to 3.18 |
|
G |
33 (33 %) |
47 (47%) |
0.56 |
0.31 to 0.98 |
|
* Significant differences ≤ 0.05 significant, p >0.05 non-significant.